UT Southwestern Medical Center, Dallas, USA
Michael Dellinger, Ph.D., received his B.S. and Ph.D. degrees in Molecular and Cellular Biology from the University of Arizona. Dr. Dellinger’s training in lymphology began while he was a graduate student in the laboratories of Drs. Marlys Witte and Robert Erickson. As a graduate student, he investigated the molecular mechanisms controlling the development of the lymphatic vasculature and the genetic underpinnings of human diseases caused by errors in this essential process.
After completing his graduate work, he joined Rolf Brekken’s laboratory at UT Southwestern Medical Center. In Dr. Brekken’s laboratory he studied the role of the VEGF-A/VEGFR2 pathway in promoting developmental and tumor lymphangiogenesis.
In 2014, Dr. Dellinger became an Assistant Professor in the Department of Surgery at UT Southwestern Medical Center. The research in his laboratory is focused on developing animal models of lymphatic anomalies and using these models to identify novel therapies to treat patients. Additionally, his laboratory studies the molecular mechanisms controlling developmental and tumor lymphangiogenesis.